The approval of novel orphan drug designations continues to grow, while many existing rare disease therapies are receiving approval for expanded indications.…

Bernie Sanders

Marathon, under heavy fire for Emflaza pricing, makes surprise deal to sell drug for $140M-plus

Eight senators pile on to Marathon's Emflaza—and its $89,000 pricing blunder

More advertising pushback: Vermont Senate seeks restraint on 'beautiful' drug ads

Rolling out new importation bill, Sanders, Cummings urge Trump to step up on drug prices

Now, it's Maryland: Pharma pushes back at state-level pricing, transparency bills

Congressional pharma critic Cummings hits back after Trump's erratic presser